melatonin has been researched along with Carotid Artery Narrowing in 3 studies
Excerpt | Relevance | Reference |
---|---|---|
"Melatonin is a pluripotent agent with potent anti-inflammatory, anti-oxidative, and neuroprotective properties." | 2.72 | Potential Role of Melatonin as an Adjuvant for Atherosclerotic Carotid Arterial Stenosis. ( Di, X; Liu, C; Ma, B; Ni, L; Niu, S; Rong, Z; Zhang, R, 2021) |
" At the end of BCCAO, melatonin highest dosage caused order 2 arteriole diameter reduction by 4." | 1.37 | Rat pial microvascular responses to melatonin during bilateral common carotid artery occlusion and reperfusion. ( Cardaci, E; Colantuoni, A; Lapi, D; Paterni, M; Vagnani, S, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Zhang, R | 1 |
Ni, L | 2 |
Di, X | 1 |
Ma, B | 1 |
Niu, S | 1 |
Rong, Z | 1 |
Liu, C | 1 |
Yang, GH | 1 |
Li, YC | 1 |
Wang, ZQ | 1 |
Liu, B | 1 |
Ye, W | 1 |
Zeng, R | 1 |
Miao, SY | 1 |
Wang, LF | 1 |
Liu, CW | 1 |
Lapi, D | 1 |
Vagnani, S | 1 |
Cardaci, E | 1 |
Paterni, M | 1 |
Colantuoni, A | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
The Protective Effect of Melatonin on Smoke-induced Vascular Injury in Human[NCT02591238] | Phase 4 | 68 participants (Actual) | Interventional | 2015-06-30 | Completed | ||
The Protective Effect of Melatonin in Patients Under Carotid Endarterectomy[NCT03115034] | Phase 4 | 60 participants (Actual) | Interventional | 2016-06-01 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
(NCT02591238)
Timeframe: Three months
Intervention | g/L (Mean) |
---|---|
IV Non-smoker + Placebo | 2.76 |
III Non-smoker + Melatonin | 2.38 |
II Smoker + Placebo | 2.89 |
I Smoker + Melatonin | 2.49 |
(NCT02591238)
Timeframe: Three months.
Intervention | umol/L (Mean) |
---|---|
IV Non-smoker + Placebo | 389 |
III Non-smoker + Melatonin | 382 |
II Smoker + Placebo | 499 |
I Smoker + Melatonin | 425 |
(NCT02591238)
Timeframe: Three months.
Intervention | mmol/L (Mean) |
---|---|
IV Non-smoker + Placebo | 4.4 |
III Non-smoker + Melatonin | 4.24 |
II Smoker + Placebo | 5.02 |
I Smoker + Melatonin | 4.79 |
(NCT02591238)
Timeframe: Three months.
Intervention | mmol/L (Mean) |
---|---|
IV Non-smoker + Placebo | 1.85 |
III Non-smoker + Melatonin | 1.95 |
II Smoker + Placebo | 2.2 |
I Smoker + Melatonin | 2.19 |
(NCT02591238)
Timeframe: Three months.
Intervention | mmol/L (Mean) |
---|---|
IV Non-smoker + Placebo | 4.51 |
III Non-smoker + Melatonin | 4.5 |
II Smoker + Placebo | 4.74 |
I Smoker + Melatonin | 4.45 |
(NCT02591238)
Timeframe: Three months.
Intervention | mmol/L (Mean) |
---|---|
IV Non-smoker + Placebo | 1.21 |
III Non-smoker + Melatonin | 1.23 |
II Smoker + Placebo | 1.42 |
I Smoker + Melatonin | 1.41 |
1 review available for melatonin and Carotid Artery Narrowing
Article | Year |
---|---|
Potential Role of Melatonin as an Adjuvant for Atherosclerotic Carotid Arterial Stenosis.
Topics: Animals; Carotid Artery Diseases; Carotid Stenosis; Humans; Melatonin | 2021 |
2 other studies available for melatonin and Carotid Artery Narrowing
Article | Year |
---|---|
Protective effect of melatonin on cigarette smoke-induced restenosis in rat carotid arteries after balloon injury.
Topics: Angioplasty, Balloon; Animals; Anti-Inflammatory Agents; Blotting, Western; Carotid Arteries; Caroti | 2014 |
Rat pial microvascular responses to melatonin during bilateral common carotid artery occlusion and reperfusion.
Topics: Analysis of Variance; Animals; Capillary Permeability; Carotid Artery, Common; Carotid Stenosis; Cer | 2011 |